Epperly Corinne 4
4 · IN8BIO, INC. · Filed May 7, 2025
Insider Transaction Report
Form 4
IN8BIO, INC.INAB
Epperly Corinne
Director
Transactions
- Disposition to Issuer
Series B Warrants (right to buy)
2025-04-27−81,967→ 0 totalExercise: $1.50Exp: 2028-12-13→ Common Stock (81,967 underlying) - Award
Series B Warrants (right to buy)
2025-04-27+81,967→ 81,967 totalExercise: $0.45Exp: 2028-12-13→ Common Stock (81,967 underlying)
Footnotes (3)
- [F1]The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share.
- [F2]Fully vested and exercisable.
- [F3]The reported securities are included within 81,967 units purchased by the Reporting Person on December 13, 2023 for $1.22 per unit. Each unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock.